The 2024 CPT® code set1 takes effect January 1, 2024. There are major changes to CPT coding associated with noncontact near-infrared spectroscopy. Prior to January 1, 2024, the only CPT coding for noncontact near-infrared spectroscopy refers to use of this technology for only a flap or a wound. The new code set contains one set of CPT codes for when noncontact near-infrared spectroscopy is used to screen for peripheral arterial disease and another set of codes for when noncontact near-infrared spectroscopy is used for any reason other than to screen for peripheral arterial disease.
Starting January 1, 2024 the codes for noncontact near-infrared spectroscopy used for any reason other than to screen for peripheral arterial disease will be:
CPT® 0640T – Noncontact near-infrared spectroscopy (e.g., for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), other than for screening for peripheral arterial disease, image acquisition, interpretation, and report; first anatomic site
AND
CPT® 0859T – Noncontact near-infrared spectroscopy (e.g.,, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), other than for screening for peripheral arterial disease, image acquisition, interpretation, and report; each additional anatomic site (List separately in addition to code for primary procedure)
Starting January 1, 2024 the code for noncontact near-infrared spectroscopy used to screen for peripheral arterial disease will be:
CPT® 0860T – Noncontact near-infrared spectroscopy (e.g.,, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), for screening for peripheral arterial disease, including provocative maneuvers, image acquisition, interpretation, and report, one or both lower extremities.
References:
[1] 2024 CPT Professional. Current Procedural Terminology (CPT®) is copyright 1966, 1970, 1973, 1977, 1981, 1983-2022 by the American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association (AMA).
